EU-Japan Biotech & Pharma Partnering Conference 2026

16 Sept – 5 Oct 2026 | Osaka, Japan

HomeAgenda
Register
Register
Register

PartnershipUpdated on 9 August 2026

Seeking EU–Japan Life Sciences Partnerships for Clinical Development, Market Entry & Business Development

About

Corvionis GmbH is a Berlin-based life sciences consultancy and strategic partnership company seeking collaboration with Japanese and European biotech, pharmaceutical and medtech companies.

We support companies in building and executing cross-border development and commercialisation strategies, with particular expertise in connecting European and Asian life sciences markets.

We are interested in partnerships involving:

  • Clinical development and translational medicine

  • Regulatory and market-entry strategy

  • Business development and strategic partnerships

  • Licensing and technology transfer

  • Partner and investor identification

  • CMC and development coordination

  • Market access and commercial strategy

  • Cross-border project execution and interim management

Our experience covers pharmaceuticals, biologics, ATMPs and cell therapies, radiopharmaceuticals, medical devices and diagnostics.

At EU–Japan Biotech & Pharma Partnering, we are particularly interested in meeting Japanese companies seeking European clinical, regulatory, commercial or strategic partners, as well as European companies looking to establish collaborations and business opportunities in Japan and the broader Asian market.

We welcome discussions on co-development, licensing, market entry, clinical collaboration and strategic partnerships.

This formulation is more suitable for the “Opportunity” page because it clearly tells other participants what Corvionis is looking for and why they should contact you, rather than simply describing the company.